Sodium–glucose cotransporter 2 inhibitors do not increase the risk of fractures in real‐world clinical practice in Korea: A national observational cohort study

AIMS/INTRODUCTION: This study aimed to determine whether sodium–glucose cotransporter 2 inhibitors (SGLT2i) were related to increased fracture risk in adults with type 2 diabetes compared with dipeptidyl peptidase‐4 inhibitors (DPP‐4i). MATERIALS AND METHODS: Between 1 May 2016 and 31 December 2018,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Kyoung Hwa, Kim, Dae Jung, Choi, Yong Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153829/
https://www.ncbi.nlm.nih.gov/pubmed/35132815
http://dx.doi.org/10.1111/jdi.13768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153829/
https://www.ncbi.nlm.nih.gov/pubmed/35132815
http://dx.doi.org/10.1111/jdi.13768

Ejemplares similares